A team of researchers at the University of Bristol is embarking on a study to investigate the link between high blood pressure and dementia thanks to a £388,000 funding boost from the charity Alzheimer’s Research UK.
COVID-19 is the UK's largest public health crisis since World War II. There is an urgent need to identify why some patients with the virus do very well whereas others need to be admitted to intensive care and may die from the disease. A new observational study aimed at identifying markers that predict how COVID-19 affects patients is being led by clinicians and academics at North Bristol NHS Trust and the University of Bristol.
Following a highly competitive process, Bristol Health Partners (BHP) is now one of only eight designated Academic Health Science Centres (AHSCs) in England. The AHSC will drive service change, leading to world-class health, clinical and economic outcomes for the regional population across Bristol, North Somerset and South Gloucestershire (BNSSG).
Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evaluate a drug combination treatment for the eye disease thanks to funding of £2.5 million by the National Institute for Health Research (NIHR). The study will be co-ordinated by the University's Bristol Trials Centre (CTEU).
A new national centre, unique in the UK and Europe, that will take research out of the laboratory and closer to the bedside to ensure more patients worldwide can access ground-breaking treatments as quickly as possible will be officially opened today [Thursday 9 June].
Major reallocation of healthcare services during the COVID-19 pandemic meant that elective surgery in children with congenital heart disease (CHD) was significantly reduced, so that those needing urgent, lifesaving and emergency surgery could be treated. However, this prioritisation of the most severely ill children did not increase overall post-operative complications rates or death, a study led by the University of Bristol has shown.
Students from the medical and dental schools of Bristol, Cardiff, Exeter and Plymouth have joined forces to launch a new journal that showcases original research undertaken in world-class laboratories and clinics by fellow students.
Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including Huntington’s disease.
Researchers have found that when the protein matrix metalloproteinase-14 (MMP-14) is reduced or lost, white blood cells, known as macrophages, become good and could prevent hardening of the arteries, rupture and sudden death.
Professor Gianni Angelini, Director of the Bristol Heart Institute at the University of Bristol, and cardiac surgeon at University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), has been honoured with a Lifetime Achievement Award from the International Society for Coronary Artery Surgery for his pioneering work.
